| INTRODUCTION
Chemotherapy plays an important role in the comprehensive treatments of breast cancer. However, multidrug resistance (MDR) represents a major obstacle to successful chemotherapy (Borst, Evers, Kool, & Wijnholds, 2000) . MDR is defined as the phenomenon of tumor cells resisting to a chemotherapeutic drug along with developing cross-resistance to a variety of chemotherapeutic drugs with different structure and function (Szakacs, Paterson, Ludwig, BoothGenthe, & Gottesman, 2006) . Among many mechanisms mediating MDR, one of the most studied is that of the enhanced cellular efflux of chemotherapeutic drugs owing to overexpression of P-glycoprotein (P-gp). Recently, a number of studies showed that cancer stem cells are related to the resistance of tumor to chemotherapeutic drugs (Dean, Fojo, & Bates, 2005) . Moreover, although several drugs such as cyclosporin A and verapamil had been used to reverse MDR of tumor (Ji, He, & Liu, 2005) , the expected side effects limited their use in clinical.
Quercetin (Que), an ubiquitous dietary flavonoid, is well known to induce growth inhibition in multiple cancer cell types, including liver (Walle, Vincent, & Walle, 2003) , breast (Schlachterman, Valle, Wall, et al., 2008) , prostate (Kim, Lee, Jeong, Guo, & Lee, 2008) , leukemia (Ramos & Aller, 2008) , gastric (Wang, Zhang, Zhang, et al., 2012) , colon (Djuric, Severson, & Kato, 2012) , and lung (Hayashi, Matsushima, Nakamura, et al., 2012) cancer and animal models. Moreover, it killed tumor cells selectively without damaging normal cells (Gibellini, Pinti, Nasi, et al., 2011) . Although previous study indicated that Que could enhance the chemosensitivity of cancer cells in a dose-dependent manner, the role of Que in reversing MDR of cancer cells by inhibiting Y-box binding protein 1 (YB-1) activity as well as the mechanism remained unreported. Therefore, in the present study, we investigated whether Que could reverse MDR in drug-resistant breast cancer cells so as to increase its chemosensitivity through downregulating P-gp expression and eliminating cancer stem cells mediated by YB-1 nuclear translocation.
| MATERIALS AND METHODS

| Materials
MCF-7 and MCF-7/dox cell lines were purchased from Beijing Zhongke Zhijian Biotechnology Co., Ltd (China). Que was purchased 
| Cell culture
RPMI-1640 supplemented with 10% FBS was used to culture MCF-7 cells and MCF-7/dox cells. Medium for MCF-7/dox cells was further supplemented with Dox (2.5 μg/ml). Dox-free medium was used to culture MCF-7/dox cells 1 week before the cells being used for experiments.
| Cell viability assay
Our studies indicated that Que had little effect on cell proliferation at concentrations less than 0.7 μm (Figure 1a) . Therefore, we preferred 
| Apoptosis and cell cycle analyses
MCF-7 cells and MCF-7/dox cells were respectively treated by 2.5 μg/ml Dox, 0.5 μg/ml Pac, or 0.5 μg/ml Vcr with or without 0.7 μm Que intervention for 24 hr. Cells treated by 2.5 μg/ml Dox with or without 0.7 μm Que intervention were harvested with trypsinization. Cell apoptosis was detected by Annexin V-FITC apoptosis detecting kit according to the manufacturer's operating instructions. Cells treated with 0.5 μg/ml Pac or 0.5 μg/ml Vcr with or without 0.7 μm Que intervention were washed twice with ice-cold phosphate-buffered saline (PBS), harvested with trypsinization, and then washed twice with ice-cold PBS again. The washed cells were fixed in precooling 70% ethanol overnight at 4°C. Cell cycles of the fixed cells were detected using Cell Cycle Analysis Kit according to the manufacturer's operating instructions.
| Western blot analysis
MCF-7 and MCF-7/dox cells were respectively treated by 2.5 μg/ml Dox, 0.5 μg/ml Pac, or 0.5 μg/ml Vcr with or without 0.7 μm Que intervention for 24 hr. Nuclear and cytosolic proteins were extracted with nuclear and cytoplasmic protein extraction kit, and total protein were extracted with cell lysis buffer according to their corresponding manufacturer's instructions. The proteins were respectively separated with sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and then transferred onto polyvinylidene difluoride membranes. The membranes containing cytosolic proteins were incubated with primary antibody GAPDH or YB-1, containing nuclear proteins were incubated with primary antibody LaminB1 or YB-1, and containing total proteins were incubated with primary antibody GAPDH or P-gp overnight at 4°C. The membranes were then incubated with corresponding second antibody and then developed using chemiluminescence detection kit.
| CD44
+ /CD24 −/low phenotype detection MCF-7 and MCF-7/dox cells were respectively treated by 2.5 μg/ml Dox, 0.5 μg/ml Pac, or 0.5 μg/ml Vcr with or without 0.7 μm Que intervention for 24 hr. The cells were washed twice with ice-cold PBS, harvested with trypsinization, and then washed twice with icecold PBS again. Incubated with 1 μl of FITC-conjugated anti-CD44
and 5 μl of PE-conjugated anti-CD24 antibodies on ice for 20 min in the dark were 100 μl of cell suspensions with density of 1 × 10 6 /ml.
The cells were resuspended with ice-cold PBS to 400 ml and then analysed using flow cytometry.
| Intracellular Dox accumulation
MCF-7 and MCF-7/dox cells were treated by 2.5 μg/ml Dox with or without 0.7 μm Que intervention for 24 hr. The cells were collected and washed twice with PBS. The collected cells were resuspended in PBS at a density of 1 × 10 6 /ml and then 400 μl of the cell suspensions were used to analyse the intracellular Dox accumulation by flow cytometry.
| Statistical analysis
Each experiment was repeated at least three times. All data were presented as mean ± SD. Statistical analysis was performed using SPSS 13.0 software. p < .05 was considered as statistically significant.
| RESULTS
Overexpression of YB-1 nuclear protein, P-gp, and CD44 + /CD24 Que mediated YB-1 nuclear translocation resulting in the decreased expression of P-gp and CD44 + /CD24 −/low phenotype in
FIGURE 4
Effects of Que on the expression of YB-1 and P-gp. MCF-7 cells and MCF-7/dox cells were respectively treated by 2.5 μg/ml Dox, 0.5 μg/ml Pac, or 0.5 μg/ml Vcr with or without 0.7 μm Que intervention for 24 hr. Western blot analysis showed that Que significantly inhibited Dox, Pac or Vcr-induced YB-1 nuclear translocation, thereby mediating downregulation of P-gp expression in MCF-7/dox cells. Dox = doxorubicin; Pac = paclitaxel; P-gp = P-glycoprotein; Que = quercetin; Vcr = vincristine; YB-1 = Y-box binding protein 1 
| DISCUSSION
YB-1 is highly regulated protein with multiple localization-dependent functions. In the nucleus, YB-1 acts as a transcription/splicing factor, whereas, in the cytoplasm, it binds to and stabilizes mRNA in order to regulate translation (Pandey, Okuda, Watabe, et al., 2011) . In the last decade, YB-1 has been identified as a principal factor in many malignant tumors (Evdokimova, Ovchinnikov, & Sorensen, 2006; Lasham, Print, Woolley, Dunn, & Braithwaite, 2013) . Recently, growing evidences indicated that the overexpression of P-gp and enhancement of cancer stem cells characteristics had a close relationship with the nuclear localization of YB-1 in cancer cells (Zhao et al., 2013; Bargou et al., 1997; To et al., 2010) . P-gp is a membrane transporter, which has a very wide substrate spectrum mediating the efflux of a variety of chemotherapeutic drugs, 
